期刊档案 · Multiple
Reproductive Medicine and Biology
ISSN 1445-5781 · eISSN 1447-0578 · WILEY · JAPAN
Reproductive Medicine and Biology 中科院 医学 3区（2025 年升级版），影响因子 4.26，完全开放获取，APC 约 1,850 美元，近 24 个月 99 篇文章投稿到接收中位 91 天，官网公布录用率 21%，2025 年发文 93 篇，SCIE、Scopus 收录。
研究范围
研究范围与定位
Reproductive Medicine and Biology 由 WILEY 出版，属中科院医学大类（2025 升级版3区）。按 OpenAlex 近年发文统计，该刊主要发表 Reproductive Biology and Fertility、Ovarian function and disorders、Sperm and Testicular Function 等主题的论文，这 3 个主题约占 48.6%，主导子领域为 Reproductive Medicine。（根据 OpenAlex 主题统计与中科院分区数据生成）
Reproductive Medicine and Biology (RMB) is the official English language open access journal of the Japan Society for Reproductive Medicine, the Japan Society of Fertilization and Implantation, the Japan Society of Andrology, and the Japan Society for Ova Research, and welcomes submissions from the members and the non-members. RMB publishes original research articles that report new findings or concepts in all aspects of reproductive phenomena in all kinds of mammals. Manuscripts in the following fields will be considered: andrology, endocrinology, oncology, immunology, genetics, function of gonads and genital tracts, erectile dysfunction, gametogenesis, function of accessory sex organs, fertilization, embryogenesis, embryo culture, embryo manipulation, early pregnancy, implantation, ontogenesis, infectious disease, contraception, infertility treatment, surgery, and ethics and social issues, at the biological, biochemical, biophysical, molecular biological, analytically morphological, and clinical levels. Reports on techniques applicable to the above fields are also considered. Original Articles, Research Notes, and Case Reports will be accepted, but not preliminary reports. Review and Mini review articles are usually submitted upon invitation by the Editors, but the Editorial Board welcomes voluntary contributions. A review should be a focused, brief treatment of a contemporary development in a single area. Editorial articles are usually submitted upon invitation by the Editors. Commentary, Opinion, Perspective are also considered for review. Abstracting and Indexing Information Academic OneFile (GALE Cengage) Biological Abstracts (Clarivate Analytics) BIOSIS Previews (Clarivate Analytics) CAS: Chemical Abstracts Service (ACS) Current Contents: Clinical Medicine (Clarivate Analytics) Embase (Elsevier) Open Access Journal Index – OAJ (NSLC & CEPIEC) PubMed (NLM) Science Citation Index Expanded (Clarivate Analytics) SCOPUS (Elsevier) Web of Science (Clarivate Analytics) Reproductive Medicine and Biology deposits all articles in PMC (PubMed Central)
摘自期刊官网 Aims & Scope
研究方向（LetPub）：Multiple
主编 Masayuki SHIMADA出版商官网
编委会国家分布：中国大陆 1 位（约 1%）；主要国家 日本 59、韩国 3、中国台湾 2、美国 2、中国 1（共 74 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Reproductive Biology and FertilityMedicine21.7%
- Ovarian function and disordersMedicine14.7%
- Sperm and Testicular FunctionMedicine12.2%
- Reproductive System and PregnancyImmunology and Microbiology8.1%
- Reproductive Health and TechnologiesMedicine6.3%
- Assisted Reproductive Technology and Twin PregnancyMedicine4.4%
- Endometriosis Research and TreatmentMedicine4.3%
- Gynecological conditions and treatmentsMedicine3.2%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 3 区 |
| 小类 | 妇产科学OBSTETRICS & GYNECOLOGY | 3 区 |
| 小类 | 生殖生物学REPRODUCTIVE BIOLOGY | 4 区 |
Top 期刊：否综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 3 区 |
| 小类 | 妇产科学OBSTETRICS & GYNECOLOGY | 3 区 |
| 小类 | 生殖生物学REPRODUCTIVE BIOLOGY | 2 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）医学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 3 区 |
| 小类 | 生殖生物学REPRODUCTIVE BIOLOGY | 3 区 |
| 小类 | 妇产科学OBSTETRICS & GYNECOLOGY | 4 区 |
Top 期刊：否综述期刊：否
数据库收录
SCIEScopusDOAJLetPub
国际期刊预警名单：各版本均未列入LetPub
期刊官网自述收录
Web of SciencePMCEmbaseCASCurrent Contents出版商官网
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 4.26LetPub ·
- 影响因子（出版商公布）
- 4.3出版商官网 ·
- 影响因子（出版商公布） 2025
- 4.3出版商官网 ·
- CiteScore 2026-06
- 6.3LetPub ·
- CiteScore（出版商公布）
- 6.3出版商官网 ·
- CiteScore（出版商公布） 2025
- 6.3出版商官网 ·
- SJR 2026-06
- 1.14LetPub ·
- SNIP 2026-06
- 1.37LetPub ·
- h-index
- 60OpenAlex ·
- i10-index
- 485OpenAlex ·
- 两年平均被引
- 4.03OpenAlex ·
- 自引率
- 7%LetPub ·
- Gold OA 文章占比
- 100%LetPub ·
发文规模
- 年文章数
- 81LetPub ·
- 年发文量（出版商公布） 2025
- 87出版商官网 ·
- 年下载量（出版商公布） 2025
- 293,822出版商官网 ·
逐年发文量 OpenAlex 统计 · 累计 1,265 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 92 | 92 | 47 |
| 2025 | 93 | 93 | 262 |
| 2024 | 64 | 64 | 695 |
| 2023 | 65 | 65 | 725 |
| 2022 | 57 | 57 | 991 |
| 2021 | 79 | 79 | 1,342 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 Crossref 登记的稿件日期 · 至
91 天投稿到接收中位数 · P25–P75 55 天 – 127 天
- 接收到上线
- 中位数 14 天（99 篇）
- 投稿到上线
- 中位数 106 天
- 样本
- 99 篇有投稿与接收日期的文章（窗口内共 181 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度（社区反馈）
- 20 WeeksLetPub ·
- 录用率（出版商公布）
- 21%出版商官网 ·
- 录用率（出版商公布） 2025
- 21%出版商官网 ·
- 投稿到首次决定
- 6 天出版商官网 ·
- 投稿到首次决定 2025
- 6 天出版商官网 ·
- 投稿到接收 2025
- 97 天出版商官网 ·
- 接收到发表 2025
- 19 天出版商官网 ·
- 投稿到发表（期刊自报）
- 约 20 周DOAJ ·
- 评审方式
- 单盲同行评审DOAJ
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
完全开放获取DOAJ
所有文章开放获取，通常向作者收取文章处理费（APC）。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | USD 1,850 / GBP 1,250 / EUR 1,650 | 有 | CC BY、CC BY-NC、CC BY-NC-ND | |
| OpenAlex | USD 1,850 / EUR 1,650 / GBP 1,250 | — | — | |
| LetPub | EUR 1,650 / GBP 1,250 / USD 1,850 | 有 | — | |
| 出版商官网 | 有，金额未公布 | — | — |
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
接收的文章类型10 种，含篇幅限制
- case reportsOriginal Articles, Research Notes, and Case Reports will be accepted, but not preliminary reports.未说明篇幅
- commentarye: In general, total of no more than 5. Commentary/Opinion/Perspective Word limit: 1500 words including abstract and references. References: no more than正文 ≤ 1,500 词 · 摘要 ≤ 100 词 · 图表 ≤ 10
- editorial articlesEditorial articles are usually submitted upon invitation by the Editors.未说明篇幅
- mini reviewthe time of submission. Word limit for Mini Review Article: In general, 8640 words including abstract and references. References for Mini Revi正文 ≤ 8,640 词
- opinionCommentary, Opinion, Perspective are also considered for review.未说明篇幅
- original articlesOriginal Articles, Research Notes, and Case Reports will be accepted, but not preliminary reports.未说明篇幅
- perspectiveCommentary, Opinion, Perspective are also considered for review.未说明篇幅
- research notesOriginal Articles, Research Notes, and Case Reports will be accepted, but not preliminary reports.未说明篇幅
- reviewReview and Mini review articles are usually submitted upon invitation by the Editors, but the Editorial Board welcomes voluntary contributions.未说明篇幅
- review articleWhether the paper will be published as Review Article or Mini Review Article will be examined based on the following bases and determined by the editorial offic…正文 ≤ 8,640 词
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、许可与版权、开放获取、同行评审、查重、预印本
- AI 使用 DISCLOSING THE USE OF ARTIFICIAL INTELLIGENCE (AI)
AI use must be described transparently and in detail in the Methods section. 模型摘要
If you or your co-authors have used Artificial Intelligence Generated Content (AIGC) tools such as ChatGPT and others based on large language models (LLMs) to develop any portion of a manuscript, their use must be described transparently and in detail in the Methods section.Find more details on Wiley’s AI guidelines for researchers and Wiley’s AI policy in full in the Best Practices Guidelines on …
原文 ↗出版商官网 ·- 作者资格 AUTHORSHIP
All listed authors should have contributed to the manuscript substantially and have agreed to the final submitted version.
原文 ↗出版商官网 ·- 利益冲突 POTENTIAL CONFLICT OF INTEREST
All authors should declare any financial support or relationship that may pose conflict of interest as “Disclosure Statement” between Acknowledgements and References sections.You should disclose any potential conflicts of interests (also referred to as “competing interests”) that might appear to affect your or your co-author’s ability to present work objectively.These might include relevant financ…
原文 ↗出版商官网 ·- 数据可用性 Data Sharing and Data Accessibility
The journal encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.
原文 ↗出版商官网 ·- 许可与版权 COPYRIGHT PERMISSIONS
Permission required for previously published figures, tables, or text passages. 模型摘要
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
原文 ↗出版商官网 ·- 开放获取 Open Access Agreement (OAA)
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
原文 ↗出版商官网 ·- 同行评审 PEER REVIEW AND ACCEPTANCE
Before peer review: Submission of a manuscript implies that the work described has not been published before; that it is not under consideration for publication elsewhere in any language and that its publication has been approved by all co-authors, if any, as well as by the responsible authorities—tacitly or explicitly—at the institute where the work has been carried out.
原文 ↗出版商官网 ·- 查重
Plagiarism, including self-plagiarism, is prohibited; manuscripts are screened by CrossCheck. 模型摘要
Journal policy prohibits use of plagiarized text, including self-plagiarism (i.e., using your own text that has previously been published).
原文 ↗出版商官网 ·- 预印本 PREPRINT POLICY
Preprint policy: articles previously available as preprints will be considered for review. 模型摘要
Reproductive Medicine and Biology will consider for review articles previously available as preprints. Authors are requested to update any pre-publication versions with a link to the final published article. Authors may also post the final published version of the article immediately after publication.
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- WILEY
- 出版国家或地区
- JAPAN
- 出版语言
- English
- ISSN
- 1445-5781
- 电子版 ISSN
- 1447-0578
- 官网最新一期
- Volume 25, Issue 1（2026 年 12 月）
- 官方链接
- 期刊主页 ↗DOAJ
- 作者指南 ↗DOAJ
- Aims & Scope ↗DOAJ
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗DOAJ
- 编委会 ↗DOAJ
- 查重政策 ↗DOAJ
常见问题
关于 Reproductive Medicine and Biology 的常见问题
Reproductive Medicine and Biology 是中科院几区期刊？
2025 年升级版分区表中，Reproductive Medicine and Biology 为医学 3区，小类 妇产科学 / 生殖生物学 3 区。2026 年新锐版分区表中为医学 3区。不同版本与大小类分区不能混用。
Reproductive Medicine and Biology 的影响因子是多少？
LetPub 汇总的最新公布影响因子为 4.26，CiteScore 为 6.3，h-index 为 60。
Reproductive Medicine and Biology 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）99 篇已发表文章登记的日期，投稿到接收的中位数为 91 天（四分位 55–127 天）；投稿社区反馈的平均审稿速度为约 20 周；期刊官网公布的录用率为 21%（2025）。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Reproductive Medicine and Biology 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 74 位编委中，中国大陆 1 位（约 1%）；人数最多的国家是 日本（59 位）、韩国（3 位）、中国台湾（2 位）。统计按编委会页面列出的机构国家计，仅供参考。
Reproductive Medicine and Biology 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Reproductive Medicine and Biology 被 SCIE、Scopus、DOAJ 收录。期刊官网自述还被 Web of Science、PMC、Embase、CAS、Current Contents 收录，该清单未与各数据库逐一核对。
Reproductive Medicine and Biology 是开放获取期刊吗？版面费多少？
Reproductive Medicine and Biology 为完全开放获取。APC 约 1,850 美元。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex、DOAJ；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。